See more : Global Information, Inc. (4171.T) Income Statement Analysis – Financial Results
Complete financial analysis of Micro-X Limited (MX1.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Micro-X Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Southern Kuzbass Coal company Public joint-stock company (UKUZ.ME) Income Statement Analysis – Financial Results
- Daido Kogyo Co., Ltd. (6373.T) Income Statement Analysis – Financial Results
- Breedon Group plc (BREE.L) Income Statement Analysis – Financial Results
- Tombstone Exploration Corporation (TMBXF) Income Statement Analysis – Financial Results
- RCM Beteiligungs AG (RCMN.DE) Income Statement Analysis – Financial Results
Micro-X Limited (MX1.AX)
About Micro-X Limited
Micro-X Limited designs, develops, and manufactures lightweight carbon nano tube-based X-ray products for the healthcare and security imaging markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; Carestream DRX Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals; and IED X-ray cameras. It also provides miniature baggage scanners to detect hidden threats concealed within passenger carry-on luggage; airport screening reimagined, a passenger self-screening airport checkpoint; and brain CT scanners for use in road and air ambulances. The company was incorporated in 2011 and is based in Tonsley, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.22M | 15.01M | 8.97M | 3.77M | 4.25M | 1.93M | 1.61M | 659.00K | 892.00K | 72.00K | 0.00 | 0.00 |
| Cost of Revenue | 9.49M | 22.11M | 21.30M | 16.73M | 11.94M | 6.52M | 8.05M | 15.28M | 17.68M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.74M | -7.11M | -12.33M | -12.96M | -7.69M | -4.59M | -6.44M | -14.62M | -16.79M | 72.00K | 0.00 | 0.00 |
| Gross Profit Ratio | 37.69% | -47.37% | -137.41% | -343.73% | -180.95% | -237.49% | -400.75% | -2,218.66% | -1,882.29% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 59.00K | 0.00 | 720.00K | 420.00K | 7.41M | 121.00K | 17.69M | 7.13M | 300.23K | 287.02K |
| General & Administrative | 17.39M | 1.10M | 1.14M | 1.40M | 1.47M | 1.67M | 1.44M | 890.00K | 609.00K | 0.00 | 129.34K | 3.21K |
| Selling & Marketing | 937.00K | 1.38M | 856.00K | 210.00K | 2.52M | 5.13M | 4.12M | 3.03M | 1.42M | 0.00 | 12.00K | 0.00 |
| SG&A | 18.32M | 9.19M | 7.44M | 2.87M | 4.00M | 6.80M | 5.56M | 3.92M | 2.03M | 464.00K | 141.34K | 3.21K |
| Other Expenses | 0.00 | 7.39M | 4.12M | 3.01M | 3.29M | 4.13M | 3.87M | 7.07M | 11.31M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 18.76M | 9.19M | 7.44M | 2.87M | 4.00M | 4.76M | 10.00M | 1.82M | 8.91M | 7.65M | 372.58K | 76.80K |
| Cost & Expenses | 28.25M | 31.30M | 28.74M | 19.60M | 15.94M | 11.28M | 18.04M | 17.10M | 26.59M | 7.65M | 372.58K | 76.80K |
| Interest Income | 40.00K | 1.00K | 21.00K | 6.00K | 7.00K | 485.00K | 158.00K | 120.00K | 2.86M | 2.59M | 12.95K | 0.00 |
| Interest Expense | 248.00K | 269.00K | 296.00K | 680.00K | 856.00K | 495.00K | 183.00K | 139.00K | 2.86M | 0.00 | 12.95K | 0.00 |
| Depreciation & Amortization | 1.54M | 1.59M | 1.43M | 2.33M | 1.97M | 744.00K | 120.00K | 79.00K | 30.00K | 2.00K | 372.58K | -76.80K |
| EBITDA | -14.35M | -14.71M | -19.02M | -13.61M | -9.29M | -11.44M | -13.10M | -19.30M | -19.25M | -7.57M | 0.00 | 0.00 |
| EBITDA Ratio | -94.28% | -98.03% | -204.40% | -358.05% | -228.72% | -669.19% | -814.87% | -2,928.22% | -2,158.30% | -10,518.06% | 0.00% | 0.00% |
| Operating Income | -13.03M | -16.30M | -19.77M | -15.83M | -11.69M | -13.25M | -13.22M | -19.38M | -19.28M | -7.58M | -372.58K | 76.80K |
| Operating Income Ratio | -85.58% | -108.62% | -220.37% | -419.81% | -274.97% | -685.97% | -822.34% | -2,940.21% | -2,161.66% | -10,520.83% | 0.00% | 0.00% |
| Total Other Income/Expenses | 3.26M | -2.95M | -977.00K | -785.00K | -420.00K | 3.91M | -3.20M | 6.60M | 11.40M | -2.72M | 56.04K | 0.00 |
| Income Before Tax | -9.77M | -17.40M | -20.74M | -16.62M | -12.11M | -9.83M | -16.59M | -12.92M | -10.74M | -10.16M | -385.53K | 76.80K |
| Income Before Tax Ratio | -64.15% | -115.97% | -231.26% | -440.63% | -284.85% | -509.27% | -1,032.67% | -1,960.55% | -1,204.15% | -14,115.28% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -6.65M | -3.66M | -1.89M | -2.04M | -3.08M | -3.84M | -7.05M | -11.31M | 0.00 | -25.91K | 0.00 |
| Net Income | -9.77M | -10.75M | -17.09M | -14.73M | -10.07M | -9.83M | -16.59M | -12.92M | -10.74M | -10.16M | -385.53K | 76.80K |
| Net Income Ratio | -64.15% | -71.67% | -190.51% | -390.64% | -236.81% | -509.27% | -1,032.67% | -1,960.55% | -1,204.15% | -14,115.28% | 0.00% | 0.00% |
| EPS | -0.02 | -0.02 | -0.04 | -0.04 | -0.04 | -0.07 | -0.11 | -0.10 | -0.17 | -0.12 | -0.02 | 0.00 |
| EPS Diluted | -0.02 | -0.02 | -0.04 | -0.04 | -0.04 | -0.07 | -0.11 | -0.10 | -0.17 | -0.12 | -0.02 | 0.00 |
| Weighted Avg Shares Out | 527.18M | 495.81M | 460.28M | 398.12M | 231.57M | 151.13M | 144.31M | 123.76M | 64.13M | 85.96M | 21.85M | 0.00 |
| Weighted Avg Shares Out (Dil) | 527.18M | 495.81M | 460.28M | 398.12M | 231.57M | 151.13M | 144.35M | 123.78M | 64.13M | 85.96M | 21.85M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports